REFERENCES
- Link M P, Goorin A M, Miser A W, et al, The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med.. 1986; 314: 1600–1606. [PUBMED], [INFOTRIEVE]
- Meyers P A, Heller G, Healey J, et al, Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience. J Clin Oncol.. 1992; 10: 5–15. [PUBMED], [INFOTRIEVE]
- Bacci G, Picci P, Ferrari S, et al, Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities: results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin. Cancer. 1993; 72: 3227–3228. [PUBMED], [INFOTRIEVE]
- Ferrari S, Bertoni F, Mercuri M, et al, Predictive factors of disease-free survival for non-metastatic osteosarcoma of the extremity: an analysis of 300 patients treated at the Rizzoli Institute. Ann Oncol.. 2001; 12: 1145–1150. [CROSSREF], [PUBMED]
- Saeter G, Elomaa I, Wahlquist Y, et al, Prognostic factors in bone sarcomas. Acta Orthop Scand Suppl.. 1997; 273: 156–160. [PUBMED], [INFOTRIEVE]
- Bielack S S, Kempf-Bielack B, Delling G. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol.. 2002; 20: 776–790. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Davis Am, Bell R S, Goodwin P J. Prognostic factors in osteosarcoma: a critical review. J Clin Oncol.. 1994; 12: 423–431. [PUBMED], [INFOTRIEVE]
- Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med.. 1971; 285: 1182–1186. [PUBMED], [INFOTRIEVE]
- Weidner N, Semple J P, Welch W R, Folkman J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med.. 1991; 324: 1–8. [PUBMED], [INFOTRIEVE]
- Weidner N, Carroll P R, Flax J, Flumenfeld W, Folkman J. Tumor angiogeneseis correlates with metastasis in invasive prostate carcinoma. Am J Pathol.. 1993; 143: 401–409. [PUBMED], [INFOTRIEVE]
- Graham C H, Rivers J, Kerbel R S, Stankiewicz K S, White W L. Extent of vascularization as a prognostic indicator in thin (<0.76 mm) malignant melanomas. Am J Pathol.. 1994; 145: 510–514. [PUBMED], [INFOTRIEVE]
- Hollingsworth H C, Kohn E C, Steinberg S M, Rothenberg M L, Meriono M J. Tumor angiogenesis in advanced stage ovarian carcinoma. Am J Pathol.. 1995; 147: 33–41. [PUBMED], [INFOTRIEVE]
- Maeda K, Chung Y S, Takatsuka S, et al, Tumour angiogenesis and tumour cell proliferation as prognostic indicators in gastric carcinoma. Br J Cancer. 1995; 72: 319–323. [PUBMED], [INFOTRIEVE]
- Takahashi Y, Kitadai Y, Bucana C D, Cleary K R, Ellis L M. Expression of vascular endothelial growth factor and its receptor, KDR correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res.. 1995; 55: 3964–3968. [PUBMED], [INFOTRIEVE]
- Macchiarini P, Fontanini G, Hardin M J, Squartini F, Angeletti C A. Relation of neovascularization to metastasis of non-small-cell lung cancer. Lancet. 1992; 340: 145–146. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Albo D, Granick M S, Jhala N, Atkinson B, Solomon M P. The relationship of angiogenesis to biological activity in human squamous cell carcinomas of the head and neck. Ann Plast Surg.. 1994; 32: 588–594. [PUBMED], [INFOTRIEVE]
- Bochner B H, Cote R J, Weidner N, et al, Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis. J Natl Cancer Inst.. 1995; 87: 1603–1612. [PUBMED], [INFOTRIEVE]
- Tomlinson J, Barsky S H, Nelson S, et al, Different patterns of angiogenesis in sarcomas and carcinomas. Clin Cancer Res.. 1999; 5: 3516–3522. [PUBMED], [INFOTRIEVE]
- Ohsawa M, Tomita Y, Kuratsu S, Kanno H, Aozasa K. Angiogenesis in malignant fibrous histiocytoma. Oncology. 1995; 52: 51–54. [PUBMED], [INFOTRIEVE]
- Kawauchi S, Fukuda T, Tsuneyoshi M. Angiogenesis does not correlate with prognosis or expression of vascular endothelial growth factor in synovial sarcomas. Oncol Rep.. 1999; 6: 959–964. [PUBMED], [INFOTRIEVE]
- Saenz N C, Heslin M J, Adsay V, et al, Neovascularity and clinical outcome in high-grade extremity soft tissue sarcomas. Ann Surg Oncol.. 1998; 5: 48–53. [PUBMED], [INFOTRIEVE]
- Heymach J V. Angiogenesis and antiangiogenic approaches to sarcomas. Curr Opin Oncol.. 2001; 13: 261–269. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Mantadakis E, Kim G, Reisch J, et al, Lack of prognostic significance of intratumoral angiogenesis in nonmetastatic osteosarcoma. J Pediatr Hematol Oncol.. 2001; 23: 286–289. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Kaya M, Wada T, Akatsuka T, et al, Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis. Clin Cancer Res.. 2000; 6: 572–577. [PUBMED], [INFOTRIEVE]
- Kaya M, Wada T, Kawaguchi S, et al, Increased pre-therapeutic serum vascular endothelial growth factor in patients with early clinical relapse of osteosarcoma. Br J Cancer. 2002; 86: 864–869. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Pluda J M. Tumor-associated angiogenesis: mechanisms, clinical implications and therapeutic strategies. Semin Oncol.. 1997; 24: 203–218. [PUBMED], [INFOTRIEVE]
- Vermuelen P B, Gasparini G, Fox S B, et al, Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. Eur J Cancer. 1996; 32A: 2472–2484
- Arndt C A, Crist W M. Common muskuloskeletal tumors of childhood and adolescence. N Engl J Med.. 1999; 341: 342–352. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Bieling P, Rehan N, Winkler P, et al, Tumor size and prognosis in aggressively treated osteosarcoma. J Clin Oncol.. 1996; 14: 848–858. [PUBMED], [INFOTRIEVE]
- Baldini N, Scotlandi K, Barbanti-Brodano G, et al, Expression of p-glycoprotein in high-grade osteosarcomas in relation to clinical outcome. N Engl J Med.. 1995; 333: 1380–1385. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Gorlick R, Huvos A G, Heller G, et al, Expression of HER2/erbB-2 correlates with survival in osteosarcoma. J Clin Oncol.. 1999; 17: 2781–2788. [PUBMED], [INFOTRIEVE]
- Bacci G, Ferrari S, Sangiorgi L, et al, Prognostic significance of serum lactate dehydrogenase in patients with osteosarcoma of the extremities. J Chemother.. 1994; 6: 204–210. [PUBMED], [INFOTRIEVE]
- Bacci G, Picci P, Ferrari S, et al, Prognostic significance of serum alkaline phosphatase measurements in patients with osteosarcoma treated with adjuvant or neoadjuvant chemotherapy. Cancer. 1993; 71: 1224–1230. [PUBMED], [INFOTRIEVE]